1-800-FLOWERS.COM (NASDAQ: FLWS) director reports $100K stock grant

Rhea-AI Filing Summary

1-800-FLOWERS.COM, Inc. director Eugene F. DeMark reported receiving 20,964 restricted shares of Class A Common Stock on 12/10/2025. The shares were issued under his compensation package as a non-employee director and are valued at $100,000 based on the closing price of the stock on the day of the annual meeting of stockholders.

The grant vests on the first anniversary of the grant date. Following this award, DeMark beneficially owns 79,013 shares of Class A Common Stock, held directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DeMark Eugene F

(Last) (First) (Middle)

TWO JERICHO PLAZA

SUITE 200

(Street)

JERICHO NY 11753

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
1 800 FLOWERS COM INC [ FLWS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	12/10/2025		A		20,964	A	$0(1)	79,013	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Restricted Shares were issued under Mr. DeMark's compensation package as a Director of the Company. Each non-employee Director of the Company receives, as of the date of the annual meeting of the stockholders, shares of Class A Common Stock valued at $100,000 based on the closing price of the stock on the day of the annual meeting of the stockholders. Such grant vests on the first anniversary of the grant date.

	/s/ Eugene F. DeMark	12/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Eugene F. DeMark report for 1-800-FLOWERS.COM (FLWS)?

Eugene F. DeMark, a director of 1-800-FLOWERS.COM, Inc., reported the acquisition of 20,964 restricted shares of Class A Common Stock on 12/10/2025 under his director compensation package.

How many FLWS shares did the director receive in this Form 4 filing?

He received 20,964 restricted shares of 1-800-FLOWERS.COM Class A Common Stock as part of his compensation as a non-employee director.

What is the stated value of the restricted share grant to the FLWS director?

The filing states that each non-employee director receives shares of Class A Common Stock valued at $100,000, based on the closing price of the stock on the day of the annual meeting of stockholders.

When do the restricted shares granted to the 1-800-FLOWERS.COM (FLWS) director vest?

The filing explains that this director equity grant vests on the first anniversary of the grant date.

How many FLWS shares does Eugene F. DeMark own after this transaction?

After the reported transaction, Eugene F. DeMark beneficially owns 79,013 shares of 1-800-FLOWERS.COM Class A Common Stock, held directly.

Is the FLWS director’s equity grant part of a standard compensation program?

Yes. The filing states that the restricted shares were issued under Mr. DeMark's compensation package as a Director, and that each non-employee director receives shares valued at $100,000 as of the date of the annual meeting of stockholders.